MaxCyte, Inc. (MXCT)
1.09
+0.01
(+0.93%)
USD |
NASDAQ |
Oct 06, 16:00
1.09
0.00 (0.00%)
After-Hours: 19:39
MaxCyte Cash from Operations (Quarterly) : -4.661M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.661M |
| March 31, 2026 | -8.169M |
| December 31, 2025 | -2.689M |
| September 30, 2025 | -7.458M |
| June 30, 2025 | -9.852M |
| March 31, 2025 | -14.41M |
| December 31, 2024 | -7.821M |
| September 30, 2024 | -4.391M |
| June 30, 2024 | -4.834M |
| March 31, 2024 | -10.56M |
| December 31, 2023 | 0.9817M |
| Date | Value |
|---|---|
| September 30, 2023 | -8.238M |
| June 30, 2023 | -10.10M |
| March 31, 2023 | -4.325M |
| December 31, 2022 | -6.086M |
| September 30, 2022 | -5.921M |
| June 30, 2022 | 0.9186M |
| March 31, 2022 | -3.694M |
| December 31, 2021 | -0.9602M |
| September 30, 2021 | -0.6904M |
| June 30, 2021 | -4.387M |
| March 31, 2021 | -4.642M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Repligen Corp. | 32.77M |
| Bio-Techne Corp. | 95.42M |
| BioLife Solutions, Inc. | 6.348M |
| MindWalk Holdings Corp. | -2.895M |
| Maravai Lifesciences Holdings, Inc. | 3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.566M |
| Cash from Financing (Quarterly) | -1.42M |
| Free Cash Flow | -23.79M |
| Free Cash Flow Per Share (Quarterly) | -0.0442 |
| Free Cash Flow to Equity (Quarterly) | -4.487M |
| Free Cash Flow to Firm (Quarterly) | -4.723M |
| Free Cash Flow Yield | -20.45% |